Dr. Saylor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
# 7E
Boston, MA 02114Phone+1 617-724-4000Fax+1 617-726-8685
Summary
- Dr. Philip Saylor is an oncologist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from University of Pittsburgh School of Medicine and has been in practice 14 years. He specializes in genitourinary oncology and hematologic oncology and is experienced in amyloidosis, hematologic oncology, prostate cancer, myelodysplasia, and myelofibrosis.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2007 - 2010
University of California (San Diego) Medical CenterResidency, Internal Medicine, 2003 - 2006
University of Pittsburgh School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2005 - 2027
RI State Medical License 2021 - 2026
MA State Medical License 2008 - 2025
ME State Medical License 2020 - 2025
NH State Medical License 2021 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- 237 citationsLong-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hos...Nicholas J. Giacalone, William U. Shipley, R.H. Clayman, Andrzej Niemierko, Michael Drumm
European Urology. 2017-06-01 - 59 citationsRadical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.Alexandre R Zlotta, Leslie K Ballas, Andrzej Niemierko, Katherine Lajkosz, Cynthia Kuk
The Lancet. Oncology. 2023-06-01 - 15 citationsBone Health and Bone-Targeted Therapies for Prostate Cancer: American Society of Clinical Oncology Endorsement Summary of a Cancer Care Ontario GuidelinePhilip J. Saylor, R. Bryan Rumble, Jeff M. Michalski
JCO Oncology Practice. 2020-02-19
Press Mentions
SUO 2023: Bone Support Throughout the Prostate Cancer JourneyNovember 30th, 2023- Outside the Guidelines: Denosumab Overuse in Prostate CancerMarch 7th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
